-
281
METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression
Published 2025-01-01“…Abstract Radiotherapy is one of the main treatment modalities for advanced hepatocellular carcinoma (HCC). Ferroptosis has been shown to promote the radiosensitivity of HCC cells, but it remains unclear whether epigenetic regulations function in this process. …”
Get full text
Article -
282
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing
Published 2025-01-01Subjects: “…Hepatocellular carcinoma (HCC)…”
Get full text
Article -
283
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
284
-
285
Prognostic Value of N1/N2 Neutrophils Heterogeneity and Tertiary Lymphoid Structure in Hepatocellular Carcinoma Patients
Published 2024-12-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
286
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy
Published 2025-01-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
287
-
288
-
289
-
290
The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
Published 2025-01-01Subjects: Get full text
Article -
291
Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma
Published 2024-12-01“…Abstract Fibrolamellar Hepatocellular Carcinoma (FLC) is a rare liver cancer characterized by a fusion oncokinase of the genes DNAJB1 and PRKACA, the catalytic subunit of protein kinase A (PKA). …”
Get full text
Article -
292
-
293
LARP3 inhibits the apoptosis of hepatocellular carcinoma via the ROS/PI3K/c-Fos axis.
Published 2025-01-01“…Hepatocellular carcinoma (HCC) accounts for 75%-85% of PHC. …”
Get full text
Article -
294
Identification of RAD51AP1 as a key gene in hepatitis B virus-associated hepatocellular carcinoma
Published 2025-01-01“…Background: Hepatocellular carcinoma (HCC) is a significant global health concern, with chronic hepatitis B virus (HBV) infection being a major contributor. …”
Get full text
Article -
295
-
296
Idarubicin-loaded drug-eluting microspheres transarterial chemoembolization for intermediate stage hepatocellular carcinoma: safety, efficacy, and pharmacokinetics
Published 2024-10-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
297
Endoplasmic reticulum stress-related CLIP4 plays a procarcinogenic role in hepatocellular carcinoma: an integrated analysis
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
298
Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis
Published 2025-01-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
299
Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study
Published 2025-01-01Subjects: “…Recurrent hepatocellular carcinoma…”
Get full text
Article -
300
Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation
Published 2019-01-01“…Liver transplantation (LT) is a curative treatment for hepatocellular carcinoma (HCC) and the underlying primary liver disease; however, tumor recurrence is still a major issue. …”
Get full text
Article